-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Zeng Zhiqiang, managing partner of Huagai Medical Fund, said at the "First National Health Industry Investment Leaders Summit" that China's current medical device industry is too small, too fragmented, lack of competitiveness, the future resources, funds will be gathered to the industry's leading enterprises.
, there are more than 14,000 medical device manufacturers, operating more than 180,000 enterprises. Zeng Zhiqiang introduced that at present, the top ten medical device enterprises only accounted for about 10% of the national medical device market share. "The top 10 international medical device giants account for 36 per cent of the global market, with a much higher concentration than at home."
, said mergers and acquisitions integration is an important means to increase industry concentration. "The growth history of leading companies is often the history of mergers and acquisitions. In the case of Medtron, the global medical device giant, Medtron's growth over the past 20 years has been accompanied by hundreds of mergers and acquisitions. According
the 2018-2020 China Health Industry Investment Research Report, jointly released by Taishanhui, Deloitte, Osteo, Lilac Park, etc., the number of listed companies in China's medical devices will exceed 100 in the next three to five years. (China Securities News)